ReleaseWire Connect

Research on Laser Medical Cosmetology Market in China, 2014-2018 mainly analyzes the policies, characteristics, competition pattern, market demand and new dynamics development trend and major medical cosmetology institutes in laser medical cosmetology industry in China.

Research and Forecast of Automotive Drive Axle Market in China, 2014-2018 mainly analyzes the policies, characteristics, competition pattern, market supply and demand, latest trend and development tendency in automotive drive axle industry. According to the statistics from China Association of Automobile Manufacturers, in 2013, the output and sales of automobile in China are 22.1168 million and 21.9841 million. In 2014, the economy can be expected to keep appropriate fast growth in China, and automobile market will grow at the rate of about 10%, the huge automobile market capacity will bring sound development space for automotive drive axle.

China is a country with scarce rubber resources. Over 80% natural rubber and over 46% synthetic rubber have to depend on importing every year, so the imbalance between supply and demand in Chinas rubber market is very obvious. Tire is the biggest rubber consuming product in China. According to the relevant statistics, at present, the consumption of rubber in tire manufacturing has accounted for 70% of the total consumption of the entire country. The waste tires in China in 2013 have reached 300 million units, equivalent to 10.8 million tons.

The global Active Pharmaceutical Ingredient market is expected to reach a market size approximately $190 billion by 2020, growing at a CAGR of more than 6.5% from 2014 to 2020. API market is mainly driven by the factors such as patent expiration of major drugs, increased generic medicine sales and high uptake of biologics. High Potential Active Pharmaceutical Ingredients (HPAPI) are also driving the API market growth globally as these compounds are very effective in treatment of diseases such as cancer, respiratory disorders and hormonal imbalances and HPAPI growth is mainly driven by its therapeutic applications in Oncology.

Diagnostic imaging market is estimated to grow at a steady CAGR of more than 5% from 2014 to 2020 to reach a market size of more than $35 billion by the end of 2020. Some of the major factors such as increasing applications of diagnostic procedures, growing awareness about early disease diagnosis among people in the emerging markets, high incidence/prevalence of diseases such as cancer, cardiovascular and neurological disorders, favorable investments in emerging markets, and the increasing research activities across the globe are boosting the market growth. However, the high cost of diagnostic imaging systems, risk of radiation exposure, and meager healthcare insurance coverage for diagnostic procedures, shortage of helium for MRI systems, and saturated markets are hindering the market growth.

The In-Vitro diagnostics are the tests performed outside the human body by isolating blood and tissue specimens for detection of body's condition, helping in the prevention and control of diseases. The global IVD market is expected to grow at a CAGR of more than 6% from 2014 to 2020 to reach a market size of more than $90 by the end of 2020. In the report, the IVD market has been segmented on the basis of techniques, products, applications, and end-users. The market assessment of the above mentioned segments is made across the geographies such as North America, Europe, Asia-Pacific, LATAM and MENA. Major factors such as technological advancements in the diagnostics, and rising healthcare awareness, increased incidence of chronic and infectious disease, demand for POCT devices are boosting the market growth However, intensified competition, reimbursement issues, and affordability of healthcare diagnostics are hindering the IVD market growth.

"Polymerase Chain Reaction (PCR) is a rapid method to amplify DNA in molecular biology field, enabling researchers to produce millions of copies of specific DNA. Though the sample quality is not so good all the time, factors such as short duration, technological advancements and the ease of procedure are boosting its adoption. The global PCR market is expected to grow at a CAGR of more than 9% from 2014 to 2020 to reach a market size of $14 billion by the end of 2020. The PCR market is mainly segmented by products, techniques, applications, and end users. The market assessment of the above mentioned segments is made across the geographies such as North America, Europe, Asia-Pacific, LATAM and MENA.

The global healthcare industry is exhibiting transformation from volume-based to value-based business. Improved quality care, fraud detection, reduced length-of-stay in hospitals and prevention of novel diseases are the main demands put-forth by payers and providers. Medical & Healthcare analytics is an emerging segment which provides logical use of data and allied business insights developed through useful systematic order such as numerical, appropriate, quantitative, prognostic and other including budding replica to drive fact-based decision making for planning, management, measurement and learning. Factors such as federal health mandates, emergence of big data and technical advancements in analytical technologies, rising incidence of ageing population and pervasiveness of chronic and infectious diseases, preference for paperless environment propels growth and digitalization of world commerce are driving the market growth. Whereas, factors such as lack of skilled labor with analytical skills, lack of patient data confidentiality and transparency, functional gap between payers and providers, stringent governmental regulations and reimbursement scenarios are hindering the market growth.

"Nuclear Medicine plays a key role in clinical decision making and is becoming an increasingly popular diagnosis and treatment method for patients. It is one of the advanced molecular imaging technologies that are gaining prominence and radio therapy is expected to dominate in the future with rise in number of emerging alpha radiation therapy. Radiopharmaceutical/Nuclear medicine global market is expected to grow at a CAGR of more than 5.5% to reach around $9 billion by 2020. Global radiopharmaceutical market is mainly classified into type (diagnosis & therapeutics), applications and end-users. The global market by diagnosis is further divided into SPECT and PET while therapeutics market is segmented into alpha, beta and brachytherapy. Diagnosis is the largest segment, accounting for more than 85% of global market share in 2013.

"Next generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced since the first human genome was sequenced, which took a decade time and around $3 billion. According to experts, in the coming years, a human genome can be sequenced at a cost of $1,000 in one to two days. In the last five years the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years. Until recently, uses of Next Generation Sequencing tools were limited to research Nowadays, NGS technologies have found applications mainly in two fields clinical diagnostics and infectious diseases. This report describes both current and future applications of NGS.